Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-12-13 to 2023-01-05
Current total value of award: $25547.76
Description: 4559407501!TYSABRI 300 MG/15 ML VIAL 15ML